Manufacturing

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

The evolution of cell-culture technology is driving the need for improvements in modeling solutions.

Cell-Culture Advances Test Bioreactor Performance Models

Large biopharmas, emerging biotechs, and CMOs are looking for novel ways to improve the productivity of biologics in a rapidly evolving biotherapeutics market.

The Search for Bioprocess Productivity Improvement

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

G-CON will provide a complete cleanroom infrastructure for GE Healthcare’s cell therapy and viral vector production platforms that will simplify early-stage manufacturing efforts.

G-CON Manufacturing and GE Healthcare Collaborate to Advance Early-Stage Cell Therapy and Viral Vector Manufacturing

The agreement gives Sanofi access to Biomunex’s proprietary bi- and multi-specific-antibody-generating platform.

Sanofi, Biomunex Sign Antibody Licensing Agreement

A new facility in California will expand Orchard Therapeutic’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells. 

Orchard Therapeutics Announces New Gene Therapy Manufacturing Facility

A collaboration using Pall’s bioprocessing technology in G-CON’s PODs enables flexible continuous bioprocessing and viral vector facility solutions.

Pall and G-CON Collaborate on Scalable Turnkey Solutions for Bioprocessing

The new platform is expected to speed up cell line development.

Sanofi Buys Berkeley Lights’ Cell Line Platform

CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.

Celonic Acquires Glycotope’s Biomanufacturing Facility

The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.

Manufacturing, Expression Systems